METACONVERT is an innovative and scientifically rigorous methadone conversion tool, meticulously developed from an extensive literature review and validated by the leading experts of the Cancer Pain Commission of the French Pain Society (SFETD).

• A solution to a complex challenge: Current methadone conversion protocols are numerous, yet no systematic comparative study exists to standardize practices.

• Precision in practice: Our research highlights a significant variability in methadone dosing across protocols, creating a pressing need for a reliable, evidence-based solution.

• Empowering professionals: METACONVERT is designed to support healthcare providers, regardless of their level of expertise in methadone conversion, offering a practical and scientifically grounded resource.

• A commitment to patients: Above all, METACONVERT reflects our unwavering dedication to improving the lives of cancer patients by providing more effective and consistent pain relief.

This tool is not just a step forward—it is a leap towards excellence in cancer pain management, merging scientific integrity with compassionate care.

We are proud to introduce a new Methadone Conversion Calculator, developed from a rigorous scientific literature review and based on seven robust protocols. This innovative tool is designed to provide clarity, precision, and consistency in methadone initiation, empowering healthcare professionals to optimize pain management for patients facing the most complex situations.